- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Fluticasone furoate and vilanterol trifenatate – July 2014
FLUTICASONE+VILANTEROL, dry powder inhaler, fluticasone furoate 100 microgram/actuation + vilanterol (as trifenatate) 25 microgram/actuation, Breo® Ellipta®, GlaxoSmithKline Australia Pty Ltd
Last updated
8 November 2023